Author:
Doane Michael J.,Gupta Shaloo,Fang Juanzhi,Laflamme Annik K.,Vo Pamela
Funder
Novartis Pharma AG, Switzerland
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Competing treatments for migraine: a headache for decision-makers;The Journal of Headache and Pain;2023-12-05
2. Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment;The Journal of Headache and Pain;2023-08-24
3. Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group clinical trials;Headache: The Journal of Head and Face Pain;2023-08-21
4. A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants;Cephalalgia;2023-06
5. Real-World Treatment Patterns and Outcomes Among Patients with Episodic Migraine in China: Results from the Adelphi Migraine Disease Specific Programme™;Journal of Pain Research;2023-02